ENTITY
HeMo Bioengineering

HeMo Bioengineering (HMB HK)

4
Analysis
Health CareHong Kong

02 Feb 2022 09:14

Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns

We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...

Logo
309 Views
Share
30 Dec 2021 09:15

Concerns and Outlook on China Neuro-Interventional Industry

The insight analyzed China neuro-interventional industry including the reason of cool-down in primary market, the product homogenization, fierce...

Logo
520 Views
Share
bullishLi Ning
31 Oct 2021 09:56

ECM Weekly (31st October 2021) - Patym, PolicyBazaar, Nykaa, HeMo, Clover Bio, UJU, Airdoc, Mitratel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
217 Views
Share
28 Oct 2021 14:47

HeMo Bioengineering (禾木生物工程) Pre-IPO: Signs of Lacking Innovation

We look at HeMo Bioengineering's main products. We are not convinced that its aspiration catheter products are innovative and competitive.

Logo
492 Views
Share
No more insights
x